These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 11349709)

  • 21. Platelet released growth factors boost expansion of bone marrow derived CD34(+) and CD133(+) endothelial progenitor cells for autologous grafting.
    Lippross S; Loibl M; Hoppe S; Meury T; Benneker L; Alini M; Verrier S
    Platelets; 2011; 22(6):422-32. PubMed ID: 21473675
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of marrow and blood cell yields from the same donors in a double-blind, randomized study of allogeneic marrow vs blood stem cell transplantation.
    Singhal S; Powles R; Kulkarni S; Treleaven J; Sirohi B; Millar B; Shepherd V; Saso R; Rowland A; Long S; Cabral S; Horton C; Mehta J
    Bone Marrow Transplant; 2000 Mar; 25(5):501-5. PubMed ID: 10713626
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human CD34+AC133+VEGFR-2+ cells are not endothelial progenitor cells but distinct, primitive hematopoietic progenitors.
    Case J; Mead LE; Bessler WK; Prater D; White HA; Saadatzadeh MR; Bhavsar JR; Yoder MC; Haneline LS; Ingram DA
    Exp Hematol; 2007 Jul; 35(7):1109-18. PubMed ID: 17588480
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prophylactic growth factor-primed donor lymphocyte infusion using cells reserved at the time of transplantation after allogeneic peripheral blood stem cell transplantation in patients with high-risk hematologic malignancies.
    Sohn SK; Jung JT; Kim DH; Lee NY; Seo KW; Chae YS; Park SW; Kim JG; Suh JS; Lee KB
    Cancer; 2002 Jan; 94(1):18-24. PubMed ID: 11815956
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Allogeneic transplantation of positively selected peripheral blood CD34+ progenitor cells from matched related donors.
    Finke J; Brugger W; Bertz H; Behringer D; Kunzmann R; Weber-Nordt RM; Kanz L; Mertelsmann R
    Bone Marrow Transplant; 1996 Dec; 18(6):1081-6. PubMed ID: 8971376
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Demonstration of donor origin of CD34+ HLA-DR- bone marrow cells after allogeneic peripheral blood transplantation with a long follow-up.
    Briones J; Urbano-Ispizua A; Orfao A; Marín P; Sierra J; Rovira M; Carreras E; Rozman C; Montserrat E
    Bone Marrow Transplant; 1998 Jan; 21(2):189-94. PubMed ID: 9489637
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Donor age and gender are the strongest predictors of marrow recovery from cadaveric vertebral bodies.
    Newman H; Reems JA; Rigley TH; Bravo D; Strong DM
    Cell Transplant; 2003; 12(1):83-90. PubMed ID: 12693668
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development and validation of a procedure to isolate viable bone marrow cells from the vertebrae of cadaveric organ donors for composite organ grafting.
    Gorantla VS; Schneeberger S; Moore LR; Donnenberg VS; Zimmerlin L; Lee WP; Donnenberg AD
    Cytotherapy; 2012 Jan; 14(1):104-13. PubMed ID: 21905958
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection of molecular targets on the surface of CD34+CD38- bone marrow cells in myelodysplastic syndromes.
    Xie W; Wang X; Du W; Liu W; Qin X; Huang S
    Cytometry A; 2010 Sep; 77(9):840-8. PubMed ID: 20662087
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hematopoietic progenitor cell content of vertebral body marrow used for combined solid organ and bone marrow transplantation.
    Rybka WB; Fontes PA; Rao AS; Winkelstein A; Ricordi C; Ball ED; Starzl TE
    Transplantation; 1995 Mar; 59(6):871-4. PubMed ID: 7701582
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Absence of a CD34- hematopoietic precursor population in recipients of CD34+ stem cell transplantation.
    Kato S; Ando K; Nakamura Y; Muguruma Y; Sato T; Yabe H; Yabe M; Hattori K; Yasuda Y; Hotta T
    Bone Marrow Transplant; 2001 Sep; 28(6):587-95. PubMed ID: 11607772
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hematopoietic progenitor cells from allogeneic bone marrow transplant donors circulate in the very early post-transplant period.
    Katayama Y; Mahmut N; Takimoto H; Maeda Y; Yano T; Kojima K; Azuma T; Hara M; Imajyo K; Takahashi S; Kai T; Ohno Y; Miyamoto T; Nagafuji K; Matsue K; Takenaka K; Teshima T; Shinagawa K; Ishimaru F; Omoto E; Harada M
    Bone Marrow Transplant; 1999 Apr; 23(7):659-65. PubMed ID: 10218841
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The methods used to collect hematopoietic stem cells].
    Hequet O
    Transfus Clin Biol; 2011 Apr; 18(2):230-4. PubMed ID: 21397542
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of granulocyte colony-stimulating factor administration in healthy donors before bone marrow harvesting.
    MacHida U; Tojo A; Takahashi S; Iseki T; Ooi J; Nagayama H; Shirafuji N; Mori S; Wada Y; Ogami K; Yamada Y; Sakamaki H; Maekawa T; Tani K; Asano S
    Br J Haematol; 2000 Mar; 108(4):747-53. PubMed ID: 10792279
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CD34+AC133+ cells isolated from cord blood are highly enriched in long-term culture-initiating cells, NOD/SCID-repopulating cells and dendritic cell progenitors.
    de Wynter EA; Buck D; Hart C; Heywood R; Coutinho LH; Clayton A; Rafferty JA; Burt D; Guenechea G; Bueren JA; Gagen D; Fairbairn LJ; Lord BI; Testa NG
    Stem Cells; 1998; 16(6):387-96. PubMed ID: 9831864
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Engraftment and multilineage expression of human bone marrow CD34- cells in vivo.
    Zanjani ED; Almeida-Porada G; Livingston AG; Porada CD; Ogawa M
    Ann N Y Acad Sci; 1999 Apr; 872():220-31; discussion 231-2. PubMed ID: 10372125
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression, regulation and function of AC133, a putative cell surface marker of primitive human haematopoietic cells.
    Majka M; Ratajczak J; Machalinski B; Carter A; Pizzini D; Wasik MA; Gewirtz AM; Ratajczak MZ
    Folia Histochem Cytobiol; 2000; 38(2):53-63. PubMed ID: 10833669
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Candidate hematopoietic stem cells from fetal tissues, umbilical cord blood vs. adult bone marrow and mobilized peripheral blood.
    Huang S; Law P; Young D; Ho AD
    Exp Hematol; 1998 Nov; 26(12):1162-71. PubMed ID: 9808056
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mature human hematopoietic cells in donor bone marrow complicate interpretation of stem/progenitor cell assays in xenogeneic hematopoietic chimeras.
    Ramírez M; Rottman GA; Shultz LD; Civin CI
    Exp Hematol; 1998 Apr; 26(4):332-44. PubMed ID: 9546317
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Randomized clinical study for two types of recombinant human granulocyte colony-stimulating factor mobilizing peripheral blood and bone marrow stem cells in patients receiving allogeneic hematopoietic stem cell transplantation].
    Zhang XH; Huang XJ; Liu DH; Liu KY; Han W; Chen H; Wang FR; Chen YH; Wang JZ; Zhao T; Wang Y; Xu LP
    Zhonghua Yi Xue Za Zhi; 2009 Aug; 89(30):2116-9. PubMed ID: 20058615
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.